06.06.2021, 1789 Zeichen

Valneva: Austrian/French specialty vaccine company Valneva announced that it has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Over 4,000 volunteers in the United Kingdom have been randomized in the Phase 3 trial “Cov-Compare” (VLA2001-301), which compares Valneva’s SARS-CoV-2 vaccine candidate, VLA2001, against AstraZeneca’s conditionally approved vaccine, Vaxzevria. Cov-Compare’s primary endpoint is to determine the immune response (Geometric Mean Titer – GMT of SARS-CoV-2-specific neutralizing antibodies) two weeks after completion of a two-dose immunization schedule administered in a four-week interval. Topline data are expected by September 2021 and submission to the UK’s Medicines and Healthcare products Regulatory Agency for regulatory approval will follow, subject to the topline data.
Valneva: weekly performance: 7.78%

S Immo: Management Board and Supervisory Board of Austrian based real estate company S Immo have clearly expressed their opposition to the takeover offer by Immofinanz published in mid-May 2021. "The Management Board clearly rejects the offer by Immofinanz. It is unattractive as it does neither take into account the current EPRA NAV, nor the expected increase in the intrinsic value of S Immo", explains Bruno Ettenauer, CEO of S Immo AG. When acquiring the S Immo share package in 2018, Immofinanz had paid a premium of 15 % on the then ERPA NAV. "The shareholders of S Immo are now – three years later – also entitled to a price that corresponds to the value of the share. The price offered is far off in this respect", Ettenauer continues his argument.
S Immo: weekly performance: 2.06%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (03/06/2021)

Christian Drastil: Wiener Börse Plausch

Kapitalmarkt-stimme.at daily voice: Servus Andreas Wölfl - das imaps Börsenspiel als grosses iFG Cup Revival und ein Österreich-Spoiler

Bildnachweis

Aktien auf dem Radar:Frequentis, Zumtobel, Wienerberger, Austriacard Holdings AG, EuroTeleSites AG, Polytec Group, OMV, ATX, ATX Prime, ATX TR, Marinomed Biotech, ATX NTR, Emerald Horizon AG, VIG, SBO, RBI, Palfinger, CA Immo, Gurktaler AG VZ, Rosenbauer, Amag, Bawag, CPI Europe AG, Österreichische Post, Telekom Austria, UBM, Airbus Group, GEA Group, E.ON , RWE, Rheinmetall.

---